Manulife (Manufacturers Life Insurance)
SMMT icon

Manulife (Manufacturers Life Insurance)’s Summit Therapeutics SMMT Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.34M Sell
298,000
-294,810
-50% -$5.23M ﹤0.01% 1252
2026
Q1 		$11.2M Buy
592,810
+151,857
+34% +$2.46M 0.01% 806
2025
Q4 		$7.71M Buy
440,953
+141,407
+47% +$2.66M 0.01% 1006
2025
Q3 		$6.19M Buy
299,546
+35,905
+14% +$871K 0.01% 1091
2025
Q2 		$5.61M Sell
263,641
-202,523
-43% -$4.62M 0.01% 1114
2025
Q1 		$8.99M Sell
466,164
-10,650
-2% -$214K 0.01% 884
2024
Q4 		$8.51M Buy
476,814
+181,185
+61% +$3.51M 0.01% 965
2024
Q3 		$6.47M Buy
295,629
+89,572
+43% +$1.25M 0.01% 1101
2024
Q2 		$1.61M Buy
206,057
+128,934
+167% +$696K ﹤0.01% 1581
2024
Q1 		$319K Buy
77,123
+1,043
+1% +$4.15K ﹤0.01% 2364
2023
Q4 		$199K Buy
76,080
+8,411
+12% +$17.3K ﹤0.01% 2632
2023
Q3 		$127K Buy
67,669
+21,149
+45% +$40.3K ﹤0.01% 2733
2023
Q2 		$117K Buy
+46,520
New +$84.9K ﹤0.01% 2794

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s SMMT Position: Q2 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Summit Therapeutics (SMMT) stake by 50% in Q2 2026, selling an estimated $5.23M and leaving 298,000 shares worth $4.34M. The position accounts for ﹤0.01% of the portfolio, ranked #1252.

Manulife (Manufacturers Life Insurance) first reported a position in SMMT in Q2 2023 and has held it in 13 quarters since. The position peaked at $11.2M in Q1 2026. 242 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

  • Manulife (Manufacturers Life Insurance) held 298,000 shares of Summit Therapeutics worth $4.34M as of Q2 2026.
  • Manulife (Manufacturers Life Insurance) sold 294,810 Summit Therapeutics shares in Q2 2026, an estimated $5.23M.
  • Summit Therapeutics made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q2 2026, its #1252 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Summit Therapeutics in Q2 2023 and has held it in 13 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Summit Therapeutics position peaked at $11.2M in Q1 2026.
  • 242 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q2 2026, filed 14 Aug 2026.